#treatment
Latest news and interesting information about treatment.
Seven-year trial for broken heart syndrome
Seven-year clinical trial for broken heart syndrome (Takotsubo) begins. Brenda Young's story and new treatment hope.
81-year-old streamer grandma arrested during livestream
81-year-old streamer grandma arrested during livestream. Sue Jaco, known as "GrammaCrackers," joked about the incident with police.
Haluk Levent in Intensive Care
Turkish singer Haluk Levent hospitalized in intensive care after stomach hemorrhage following a concert. Condition is under control.
US doctor in contact with Ebola patient heading to Czech hospital
A US doctor exposed to Ebola is being transferred from Uganda to a Czech hospital as a precaution. Officials assure no risk to the public.
H.C. Wainwright Reiterates Protara Buy Rating
H.C. Wainwright reiterates Buy rating on Protara Therapeutics (TARA) with $27 target. Encouraging results from lymphatic malformation and bladder cancer trials.
Jefferies Initiates SAB Biotherapeutics with Buy
Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.
Iovance Biotherapeutics: stock gains on melanoma data
Iovance Biotherapeutics stock gains momentum on real-world melanoma data for Amtagvi. Despite losses, analysts see upside from manufacturing efficiencies and label expansion.
Uganda Bans Handshakes: Ebola Threat Grows
Uganda bans handshakes to curb Ebola spread after two cases confirmed. Health officials take urgent measures.
ADB allocates $3.5 billion to Caspian countries
Asian Development Bank allocates $3.5 billion to Caspian countries for water projects, discusses new initiatives with Azerbaijan.
Relmada TX Q1 2026: Loss and stock dip
Relmada Therapeutics Q1 2026 results: stock declines, strong cash position and NDV-01 program in focus.
Relay Therapeutics stock surges 15%
Relay Therapeutics stock surges 15% after positive data from Phase 2 trial for zovegalisib in vascular anomalies.
Korro Bio adds AATD candidate KRRO-111 to pipeline
Korro Bio adds AATD treatment candidate KRRO-111 to pipeline. Preclinical data shows promising editing efficiency.
Oppenheimer Reiterates Outperform on UroGen Pharma
Oppenheimer reiterates Outperform on UroGen Pharma with $40 target. Strong commercial momentum for Zusduri driven by physician enthusiasm.
How Is Drinking Water Safety Checked?
How is drinking water safety checked in Azerbaijan? Official statement from the Ministry of Health's Republican Center of Hygiene and Epidemiology.
Ebola patient moved to Germany for treatment
Germany prepares to treat a U.S. citizen with Ebola from DRC. Read more on Bond.az.
CBL-514: New Obesity Data Revealed
Caliway Biopharmaceuticals reveals new data on CBL-514 for obesity. Combination therapy boosts weight loss by 91.5%.
Genentech to Present Breast Cancer Data at ASCO Meeting
Genentech will present breast cancer data on giredestrant and other drugs at the 2026 ASCO meeting.
Telix completes enrollment in glioblastoma therapy trial
Telix Pharmaceuticals completes patient enrollment for TLX101-Tx glioblastoma therapy trial.
BofA raises Candel price target to $9
BofA raises Candel price target to $9 after 39% improvement in prostate cancer survival data.
US CDC confirms one American tests positive for Ebola
US CDC confirms one American tested positive for Ebola. Patient to be transferred to Germany for treatment. Risk to US remains low.
Lamine Yamal to miss World Cup opener
Lamine Yamal injured, will miss Spain's first World Cup match. Details on Bond.az.
Quantum BioPharma stock surges on MS imaging study progress
Quantum BioPharma stock surges 10% on promising MS imaging study progress with Massachusetts General Hospital.
Congo Ebola outbreak: Health workers race to frontlines
Congo Ebola outbreak spreads rapidly. Health workers race to frontlines. WHO declares emergency. Latest updates on Bond.az.
FDA Accepts Viatris Fast-Acting Meloxicam
FDA accepts Viatris' New Drug Application for fast-acting meloxicam (MR-107A-02), a non-opioid option for acute pain treatment.
DT-216P2 Shows Promise in Friedreich Ataxia Trial
Design Therapeutics announces positive Phase 1/2 trial data for DT-216P2 in Friedreich ataxia, showing clinical improvements and good tolerability.
Wyndham Hotels Announces Executive Changes and CEO Health Update
Wyndham Hotels announces executive changes and CEO health update. Geoff Ballotti undergoing treatment, new chief accounting officer appointed.
Trump psychedelic order boosts investor interest
Trump's executive order on psychedelics boosts investor interest but researchers urge caution.
Terror alert in Modena: Meloni cuts short visit
Terror alert in Modena: Giorgia Meloni cuts short her visit to Cyprus after a car-ramming incident. Seven injured, two legs amputated.
Rare, untreatable Ebola strain - global emergency
WHO declares global emergency over rare, untreatable Bundibugyo Ebola strain. Outbreak spreads in Congo and Uganda, no approved vaccine or treatment.
Kansas judge blocks gender transition ban for minors
A Kansas judge blocks a ban on gender-transition treatments for minors. ACLU applauds, AG Kobach vows appeal. Find out more on Bond.az.
...